共 50 条
- [1] Tocilizumab and remdesivir in hospitalized patients with severe COVID-19 pneumonia: a randomized clinical trial[J]. INTENSIVE CARE MEDICINE, 2021, 47 (11) : 1258 - 1270Rosas, Ivan O.Diaz, GeorgeGottlieb, Robert L.Lobo, Suzana M.Robinson, PhilipHunter, Bradley D.Cavalcante, Adilson W.Overcash, J. ScottHanania, Nicola A.Skarbnik, AlanGarcia-Diaz, JuliaGordeev, IvanCarratala, JordiGordon, OliverGraham, EmilyLewin-Koh, NicholasTsai, LarryTuckwell, KatieCao, HuyenBrainard, DianaOlsson, Julie K.
- [2] Tocilizumab in Hospitalized Patients with Severe Covid-19 Pneumonia[J]. NEW ENGLAND JOURNAL OF MEDICINE, 2021, 384 (16): : 1503 - 1516Rosas, I. O.Brau, N.Waters, M.Go, R. C.Hunter, B. D.Bhagani, S.Skiest, D.Aziz, M. S.Cooper, N.Douglas, I. S.Savic, S.Youngstein, T.Del Sorbo, L.Gracian, A. CubilloDe la Zerda, D. J.Ustianowski, A.Bao, M.Dimonaco, S.Graham, E.Matharu, B.Spotswood, H.Tsai, L.Malhotra, A.
- [3] Effect of Tocilizumab vs Usual Care in Adults Hospitalized With COVID-19 and Moderate or Severe Pneumonia A Randomized Clinical Trial[J]. JAMA INTERNAL MEDICINE, 2021, 181 (01) : 32 - 40Hermine, OlivierMariette, XavierTharaux, Pierre-LouisResche-Rigon, MatthieuPorcher, RaphaelRavaud, Philippe
- [4] Effect of Tocilizumab vs Standard Care on Clinical Worsening in Patients Hospitalized With COVID-19 Pneumonia A Randomized Clinical Trial[J]. JAMA INTERNAL MEDICINE, 2021, 181 (01) : 24 - 31Salvarani, CarloDolci, GiovanniMassari, MarcoMerlo, Domenico FrancoCavuto, SilvioSavoldi, LuisaBruzzi, PaoloBoni, FabrizioBraglia, LucaTurra, CaterinaBallerini, Pier FerruccioSciascia, RobertoZammarchi, LorenzoPara, OmbrettaScotton, Pier GiorgioInojosa, Walter OmarRavagnani, VivianaSalerno, Nicola DuccioSainaghi, Pier PaoloBrignone, AlessandroCodeluppi, MauroTeopompi, ElisabettaMilesi, MaurizioBertomoro, PerlaClaudio, NorbiatoSalio, MarioFalcone, MarcoCenderello, GiovanniDonghi, LorenzoDel Bono, ValerioColombelli, Paolo LuigiAngheben, AndreaPassaro, AngelinaSecondo, GiovanniPascale, RenatoPiazza, IlariaFacciolongo, NicolaCostantini, Massimo
- [5] Tocilizumab in Patients Hospitalized with Covid-19 Pneumonia[J]. NEW ENGLAND JOURNAL OF MEDICINE, 2021, 384 (01): : 20 - 30Salama, CarlosHan, JianYau, LindaReiss, William G.Kramer, BenjaminNeidhart, Jeffrey D.Criner, Gerard J.Kaplan-Lewis, EmmaBaden, RachelPandit, LavannyaCameron, Miriam L.Garcia-Diaz, JuliaChavez, VictoriaMekebeb-Reuter, Marthade Menezes, Ferdinando LimaShah, ReenaGonzalez-Lara, Maria F.Assman, BeverlyFreedman, JamieMohan, Shalini, V
- [6] Adding colchicine to tocilizumab in hospitalized patients with severe COVID-19 pneumonia: An open-label randomized controlled trial[J]. MEDICINE, 2022, 101 (39) : E30618Rahhal, AlaaNajim, MostafaAljundi, Amer HusseinMahfouz, AhmedAlyafei, Sumaya MehdarAwaisu, AhmedHabib, Mhd BaraaObeidat, IbrahimFaisal, Mohanad MohammedAlanzi, Meshaal AliNair, Arun PrabhakaranElhassan, AreegAl-Dushain, AbdullahAbdelmajid, Alaaeldin AbdelmajidAbdelgader, Ahmed ElfadilMoursi, Ahmed Mahmoud AhmedAlharafsheh, Ahmad Eid NazzalAbou Kamar, Mohd RaghebGoravey, WaelOmar, Amr SalahAbukhattab, MohammedKhatib, Mohamad YahyaMohamedali, Mohamed GaafarAlMaslamani, Muna A. RahmanAlemadi, Samar
- [7] Tocilizumab in Patients Hospitalized with Covid-19 Pneumonia Replay[J]. NEW ENGLAND JOURNAL OF MEDICINE, 2021, 384 (15): : 1474 - 1474Stone, John H.
- [8] Tocilizumab in Patients Hospitalized with Covid-19 Pneumonia Reply[J]. NEW ENGLAND JOURNAL OF MEDICINE, 2021, 384 (15): : 1473 - 1474Salama, CarlosMohan, Shalini V.
- [9] Umifenovir in hospitalized moderate to severe COVID-19 patients: A randomized clinical trial[J]. INTERNATIONAL IMMUNOPHARMACOLOGY, 2021, 99Darazam, Ilad AlaviShokouhi, ShervinMardani, MasoudPourhoseingholi, Mohamad AminRabiei, Mohammad MahdiHatami, FirouzeShabani, MinooshMoradi, OmidGharehbagh, Farid JavandoustIrvani, Seyed Sina NaghibiAmirdosara, MahdiHajiesmaeili, MohammadrezaRezaei, OmidvarKhoshkar, AliLotfollahi, LeghaGachkar, LatifDehbsneh, Hadiseh ShabanpourKhalili, NegarSoleymaninia, AzamKusha, Akram HoseyniShoushtari, Maryam TalebTorabinavid, Parham
- [10] Tocilizumab versus baricitinib in hospitalized patients with severe COVID-19: an open label, randomized controlled trial[J]. CLINICAL MICROBIOLOGY AND INFECTION, 2023, 29 (03) : 372 - 378Karampitsakos, TheodorosPapaioannou, OuraniaTsiri, PanagiotaKatsaras, MatthaiosKatsimpris, AndreasKalogeropoulos, Andreas P.Malakounidou, ElliZarkadi, EiriniTsirikos, GeorgiosGeorgiopoulou, VasilikiSotiropoulou, VasilinaKoulousousa, ElectraChourpiliadi, CharikleiaMatsioulas, ApostolosLagadinou, MariaSampsonas, FotiosAkinosoglou, KarolinaMarangos, MarkosTzouvelekis, Argyris